These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25424944)

  • 1. Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an accelerated approach toward epitope-driven vaccine development.
    Abdel-Hady KM; Gutierrez AH; Terry F; Desrosiers J; De Groot AS; Azzazy HM
    Hum Vaccin Immunother; 2014; 10(8):2366-77. PubMed ID: 25424944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promiscuous prediction and conservancy analysis of CTL binding epitopes of HCV 3a viral proteome from Punjab Pakistan: an in silico approach.
    Shehzadi A; Ur Rehman S; Idrees M
    Virol J; 2011 Feb; 8():55. PubMed ID: 21303499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of T-cell epitopes of hepatitis C virus genotype 5a.
    Gededzha MP; Mphahlele MJ; Selabe SG
    Virol J; 2014 Nov; 11():187. PubMed ID: 25380768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sequence-based in silico analysis of well studied hepatitis C virus epitopes and their variants in other genotypes (particularly genotype 5a) against South African human leukocyte antigen backgrounds.
    Prabdial-Sing N; Puren AJ; Bowyer SM
    BMC Immunol; 2012 Dec; 13():67. PubMed ID: 23227878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of T cell and B cell epitopes against Indian HCV-genotype-3a for vaccine development- An in silico analysis.
    Chauhan V; Singh MP; Ratho RK
    Biologicals; 2018 May; 53():63-71. PubMed ID: 29519752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Empirical fitness models for hepatitis C virus immunogen design.
    Hart GR; Ferguson AL
    Phys Biol; 2015 Nov; 12(6):066006. PubMed ID: 26599153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploiting information inherent in binding sites of virus-specific antibodies: design of an HCV vaccine candidate cross-reactive with multiple genotypes.
    Grollo L; Torresi J; Drummer H; Zeng W; Williamson N; Jackson DC
    Antivir Ther; 2006; 11(8):1005-14. PubMed ID: 17302370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-silico analysis of putative HCV epitopes against Pakistani human leukocyte antigen background: An approach towards development of future vaccines for Pakistani population.
    Ashraf NM; Bilal M; Mahmood MS; Hussain A; Mehboob MZ
    Infect Genet Evol; 2016 Sep; 43():58-66. PubMed ID: 27166094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype 1 and global hepatitis C T-cell vaccines designed to optimize coverage of genetic diversity.
    Yusim K; Fischer W; Yoon H; Thurmond J; Fenimore PW; Lauer G; Korber B; Kuiken C
    J Gen Virol; 2010 May; 91(Pt 5):1194-206. PubMed ID: 20053820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broad Spectrum Peptide Vaccine Design Against Hepatitis C Virus.
    Dewi SK; Ali S; Prasasty VD
    Curr Comput Aided Drug Des; 2019; 15(2):120-135. PubMed ID: 30280672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of conserved epitopes from hepatitis C virus for pan-populational stimulation of T-cell responses.
    Molero-Abraham M; Lafuente EM; Flower DR; Reche PA
    Clin Dev Immunol; 2013; 2013():601943. PubMed ID: 24348677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential virus-specific CD8
    Luxenburger H; Graß F; Baermann J; Boettler T; Marget M; Emmerich F; Panning M; Thimme R; Nitschke K; Neumann-Haefelin C
    J Viral Hepat; 2018 Jul; 25(7):779-790. PubMed ID: 29397015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, immunogenicity and diagnostic value of envelope proteins from an Egyptian hepatitis C virus isolate.
    Shawky H; Maghraby AS; Solliman Mel-D; El-Mokadem MT; Sherif MM; Arafa A; Bahgat MM
    Arch Virol; 2015 Apr; 160(4):945-58. PubMed ID: 25631616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-genotype-reactivity of the immunodominant HCV CD8 T-cell epitope NS3-1073.
    Fytili P; Dalekos GN; Schlaphoff V; Suneetha PV; Sarrazin C; Zauner W; Zachou K; Berg T; Manns MP; Klade CS; Cornberg M; Wedemeyer H
    Vaccine; 2008 Jul; 26(31):3818-26. PubMed ID: 18582999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the existing knowledge of immunoreactivity against hepatitis C virus (HCV).
    Kim Y; Vaughan K; Greenbaum J; Peters B; Law M; Sette A
    PLoS One; 2012; 7(5):e38028. PubMed ID: 22675428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Immunoinformatics Tools for Swine: Designing Epitope-Driven Vaccines, Predicting Vaccine Efficacy, and Making Vaccines on Demand.
    Moise L; Gutiérrez AH; Khan S; Tan S; Ardito M; Martin WD; De Groot AS
    Front Immunol; 2020; 11():563362. PubMed ID: 33123135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral vectored hepatitis C virus vaccines generate pan-genotypic T cell responses to conserved subdominant epitopes.
    Donnison T; von Delft A; Brown A; Swadling L; Hutchings C; Hanke T; Chinnakannan S; Barnes E
    Vaccine; 2020 Jul; 38(32):5036-5048. PubMed ID: 32532545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transmitted/Founder Viruses Rapidly Escape from CD8+ T Cell Responses in Acute Hepatitis C Virus Infection.
    Bull RA; Leung P; Gaudieri S; Deshpande P; Cameron B; Walker M; Chopra A; Lloyd AR; Luciani F
    J Virol; 2015 May; 89(10):5478-90. PubMed ID: 25740982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reverse vaccinology approach for identification of epitopes from E1 protein as peptide vaccine against HCV: A proof of concept.
    Meshram R; Kolte B; Gacche R
    Vaccine; 2024 Oct; 42(24):126106. PubMed ID: 38971664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
    Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
    Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.